Meta's Quest launch lifts Virtuix orders about 150%, but sales fell
Virtuix (VTIX) reported Q1 FY2027 results with Omni One orders up 72% YoY and 150% since Meta's Quest launch. Net sales fell 26% to $0.8M, but gross profit rose 29% to $227,158. Net loss widened to $7.2M. The company expanded into defense, enterprise robotics (Tesla's Optimus), NASA missions, and healthcare (Sirica Therapeutics).
How this was made
The 30-second read
Why it matters
Earnings release provides fresh data on order trends, margins, and cash position, informing short‑term trading decisions.
Market read
Micro‑cap stock with recent volatility; earnings data may drive near‑term price action.
What to watch
Potential future contracts with NASA and Tesla may unlock longer‑term upside.
Background
Virtuix reported FY2027 Q1 results, noting a 150% jump in Omni One orders after Meta Quest integration.
Ticker impact
First-quarter FY2027 earnings released with new orders, sales decline and widened loss.
Potential short‑term upside to $1.80 if order momentum continues; downside risk if cash burn accelerates.
Order surge (+150%) is positive, but revenue drop and cash burn may limit upside; market already priced a ~4% move.
Market effects
Highlights growing demand for VR training in defense and enterprise robotics.
U.S. defense and tech sectors may see modest interest.
Limited to niche VR/AR hardware market.
Counterpoint
Cash burn and declining sales could pressure the stock despite order growth.
Key entities
- companyVirtuix Holdings Inc.
NASDAQ‑listed VR training hardware provider.
- partnerMeta Platforms Inc.
Collaborated on Omni One for Quest.



